Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goetinck

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
The American Journal of Pathology|November 30, 2005
Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic diseaseYunliang Chen, Xu Shi-Wen, Jonathan van Beek, et al.
The Journal of Clinical Investigation|May 21, 2010
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4Dianhua Jiang, Jiurong Liang, Gabriele S Campanella, et al.
Arthritis and Rheumatism|February 2, 2008
Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblastsYunliang Chen, Andrew Leask, David J Abraham, et al.
Disease Models & Mechanisms|March 22, 2014
Cryptosporidium parvum-induced ileo-caecal adenocarcinoma and Wnt signaling in a mouse modelSadia Benamrouz, Valerie Conseil, Magali Chabé, et al.
Plos One|December 14, 2011
Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathwayAlexandra V Finsen, Ida G Lunde, Ivar Sjaastad, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The American Journal of Pathology|November 30, 2005
Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic diseaseYunliang Chen, Xu Shi-Wen, Jonathan van Beek, et al.
The Journal of Clinical Investigation|May 21, 2010
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4Dianhua Jiang, Jiurong Liang, Gabriele S Campanella, et al.
Arthritis and Rheumatism|February 2, 2008
Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblastsYunliang Chen, Andrew Leask, David J Abraham, et al.
Disease Models & Mechanisms|March 22, 2014
Cryptosporidium parvum-induced ileo-caecal adenocarcinoma and Wnt signaling in a mouse modelSadia Benamrouz, Valerie Conseil, Magali Chabé, et al.
Plos One|December 14, 2011
Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathwayAlexandra V Finsen, Ida G Lunde, Ivar Sjaastad, et al.
Pageof 11